Cardiac Toxicity and Prognostic Value of New Echocardiographic Indicators in the Treatment of Primary Multiple Myeloma
Condition: Multiple Myeloma Intervention: Other: Chemotherapy and/or autologous hematopoietic stem cell transplantation Sponsor: Qilu Hospital of Shandong University Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Chemotherapy | Myeloma | Research | Stem Cell Therapy | Stem Cells | Toxicology | Transplants